Logo

⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy

Official Title: Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy

Study ID: NCT00431067

Conditions

Breast Neoplasms

Interventions

BIBW 2992

Study Description

Brief Summary: The primary objective of this trial is to explore the efficacy of BIBW 2992 in HER2 positive metastatic breast cancer patients after failure of trastuzumab containing regimens.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

1200.11.3 Boehringer Ingelheim Investigational Site, Scottsdale, Arizona, United States

1200.11.7 Boehringer Ingelheim Investigational Site, Encinitas, California, United States

1200.11.4 Boehringer Ingelheim Investigational Site, Santa Monica, California, United States

1200.11.2 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States

1200.11.1 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States

1200.11.5 Boehringer Ingelheim Investigational Site, Chapel Hill, North Carolina, United States

1200.11.4401 Boehringer Ingelheim Investigational Site, Bournemouth, , United Kingdom

1200.11.4402 Boehringer Ingelheim Investigational Site, Crownhill, Plymouth, , United Kingdom

1200.11.4406 Boehringer Ingelheim Investigational Site, Guildford, , United Kingdom

1200.11.4405 Boehringer Ingelheim Investigational Site, London, , United Kingdom

1200.11.4404 Boehringer Ingelheim Investigational Site, Poole, , United Kingdom

1200.11.4403 Boehringer Ingelheim Investigational Site, Truro, , United Kingdom

Contact Details

Name: Boehringer Ingelheim

Affiliation: Boehringer Ingelheim

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: